Umbrella Access Programs (UAP) – A Pioneering, Multi-Stakeholder Approach to Early Access
Umbrella Access Programs (UAP) – A Pioneering, Multi-Stakeholder Approach to Early Access
Heather Manna, VP, Global Regulatory Affairs, Inceptua Early Access, answers questions about Real World Data and Early Access.
We asked Mark Bainbridge, Sr. Director, Inceptua Early Access, to answer 5 quick questions about the important role Early Access is playing…
MoCD Type A is a rapidly progressive autosomal recessive inborn error of metabolism
Apealea is the first Cremophor-free formulation of paclitaxel approved in combination with carboplatin for ovarian cancer.
Heather Manna joins the Inceptua Early Access business unit as Vice President Global Regulatory Affairs
